Tuesday, November 22, 2011 10:22:43 PM
Thought I would post this here as well
Lodrane D This is the new Lodrane. Per the conference call this is selling better then original Lodrane formulations in the same timeframe. Elite was operationally profitable from the original Lodrane products below.
Lodrane Once a Day Original Lodrane Products. Elite has been working with HITK since mid 2010 range to secure NDA with FDA. Active ingrediants have been on the market for decades
Lodrane 24D Original Lodrane Products. Elite has been working with HITK since mid 2010 range to secure NDA with FDA. Active ingrediants have been on the market for decades
Phentermine Top Diet drug. Sales are progressing well since Launch per the Conference call
Methadone Contract Manufacturing with The Pharma Network/Ascend labs. Based on 2006 numbers, this is a 60m - 100m drug.
Hydromorphone FDA approved but pending CBE 30. Also known as Dilaudid. Pre Approval inspection completed in August. Hydromorphone and Naltrexone are combined 120m drug http://www.healthcarepackaging.com/archives/2010/09/elite_pharmaceuticals_announce.php
Naltrexone FDA approved but pending CBE 30. Pre Approval inspection completed in August. Also a key ingrediant in Eli 216. Hydromorphone and Naltrexone are combined 120m drug http://www.healthcarepackaging.com/archives/2010/09/elite_pharmaceuticals_announce.php
Undisclosed ANDA Also pre-Approval inspection completed in mid August. Can't hardly wait to hear what this is but I am guessing another pain med since that is Elites specialty
HITK ANDA #3 http://www.healthcarepackaging.com/archives/2010/09/elite_pharmaceuticals_announce.php
HITK ANDA #4 http://www.healthcarepackaging.com/archives/2010/09/elite_pharmaceuticals_announce.php
Eli 154 24 hour Oxy. Massive revenue. If you know anything about pain meds, you know how big this is. Measured in hundreds of millions. We have a partner willing to fund only half due to internal policies. Listen to the cc. Patents have reached discussion level with the patent office. Read up for yourself. Branded Product.
Eli 216 Abuse resistant Oxy. Even bigger then 154. Commercial batches started per the conf call. Commercial batches are a pre-req to approval, PH3 trials. It shows that Elite is able to produce the drug on a commercial basis and keep all the same properties. Again measured in hundreds of millions. Branded products
HITK Intermediate for 100m generic Pending HITK ANDA approval I believe. http://www.globenewswire.com/newsroom/news.html?d=210753
8 Epic drugs from agreement Elite get 15% of profit from each drug in return for milestone shares, and maybe warrants. Epic is half of Elites BOD and closely tied to Actavis/Mikah. Epic already uses Elites facility to make some drugs.
ANDA From Epic Trying to find more data on this
MIK001 classified R&D project with Mikah/Actavis. Listen to the CC. Speculation is utilizing Elites unique technology to formulate hard to make extended release drugs. Actavis has generic Oxycontin.
Isradipine 2.5mg Contract manufacturing with Actavis/Mikah. Isradipine is a 50m drug with few manufacturers. Maybe have been part of a monopoly issue with Actavis. Again tells you how few manufacturers there are.
Isradipine 5mg Contract manufacturing with Actavis/Mikah. Isradipine is a 50m drug with few manufacturers. Maybe have been part of a monopoly issue with Actavis. Again tells you how few manufacturers there are.
Phendimetrazine Tartrate 35 mg another contract manufacturing drug with Mikah/Actavis
Anti-infective ANDA From Elite website
Gastrointestinal ANDA From Elite website
7 mostly pain meds from Mikah Website http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_E/threadview?m=te&bn=99215&tid=107922&mid=107922&tof=16&frt=1#107922
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM